LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 66 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $459,263 | +54.6% | 116,269 | +22.5% | 0.00% | +50.0% |
Q2 2023 | $297,156 | -77.0% | 94,938 | -66.8% | 0.00% | -71.4% |
Q1 2023 | $1,294,380 | -31.8% | 285,735 | +62.5% | 0.01% | +40.0% |
Q4 2021 | $1,898,000 | -6.4% | 175,870 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $2,028,000 | – | 175,870 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 3,414,468 | $8,720,383 | 2.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $53,026,447 | 1.13% |
Opaleye Management Inc. | 1,390,000 | $4,350,700 | 1.04% |
DAFNA Capital Management LLC | 350,373 | $1,096,667 | 0.30% |
MANGROVE PARTNERS IM, LLC | 805,815 | $2,522,201 | 0.18% |
Atlas Venture Advisors, Inc. | 292,184 | $914,536 | 0.16% |
Verition Fund Management LLC | 2,716,713 | $8,503,312 | 0.11% |
Woodline Partners LP | 1,681,913 | $5,264,388 | 0.06% |
Fi3 FINANCIAL ADVISORS, LLC | 25,548 | $79,965 | 0.04% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 363,505 | $1,137,771 | 0.04% |